文献速递流行病学与生物统计真实世界研究与卫生经济

序贯多分配随机试验的成本效果分析

Cost-Effectiveness Analyses for Sequential Multiple Assignment Randomized Trials.
PubMed 文献 · Stat Med · 2026-01-01

序贯多分配随机试验(SMART)日益流行,其方案常提出对嵌入式自适应策略进行成本效果分析,通常采用增量成本效果比(ICER)评估。本文提出SMART设计中嵌入式动态治疗方案的ICER估计与推断方法,具体描述基于影响曲线推断的靶向最大似然估计,并通过模拟展示方法性能。全文以ADAPT-R试验(NCT02338739)为例,给出旨在提高HIV护理依从性的嵌入式方案的ICER估计及推断。本文是最早呈现SMART成本效果分析结果的手稿之一。

要点

  • SMART中嵌入式动态治疗方案的ICER可用靶向最大似然估计进行估计与推断。
  • 方法通过模拟评估性能,并以ADAPT-R试验为例展示ICER估计及推断。
  • 本文为最早呈现SMART成本效果分析结果的研究之一。

核心结论

  • 本文提出了SMART设计中嵌入式动态治疗方案ICER的估计与推断方法,并以ADAPT-R试验为例给出结果。

研究设计与样本

  • 方法学论文,提出基于影响曲线推断的靶向最大似然估计,并通过模拟评估性能。
  • 以ADAPT-R试验(NCT02338739)的嵌入式方案为实例进行成本效果分析。

主要发现

  • 模拟展示了所提估计与推断方法的性能。
  • 以ADAPT-R试验为例给出旨在提高HIV护理依从性的嵌入式方案的ICER估计及推断。

临床怎么用

  • 在SMART设计下可用所提靶向最大似然估计对嵌入式方案的ICER进行估计与推断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Sequential multiple assignment randomized trials (SMARTs) have grown in popularity in recent years, and many of their study protocols propose conducting a cost-effectiveness analysis of the adaptive strategies embedded within them. The cost-effectiveness of these regimes is often proposed to be assessed using incremental cost-effectiveness ratios (ICERs). In this paper, we present an estimation and inference procedure for such cost-effectiveness measures for the embedded dynamic treatment regimes within a SMART design. In particular, we describe a targeted maximum likelihood estimator for the ICER of a SMART's embedded regimes with influence curve-based inference. We illustrate the performance of these methods using simulations. Throughout, we use as illustration a cost-effectiveness analysis for the Adaptive Strategies for Preventing and Treating Lapses of Retention in HIV Care (ADAPT-R; NCT02338739) trial, presenting estimated ICERs (with inference) for embedded regimes aimed at increasing HIV care adherence. This manuscript is one of the first to present cost-effectiveness analysis results from a SMART.

来源:Stat Med,查看原文。版权归原作者所有。

引用

  1. Montoya LM, Geng EH, Adhiambo HF, et al. Cost-Effectiveness Analyses for Sequential Multiple Assignment Randomized Trials. Stat Med. 2026. PMID: 42267580. doi:10.1002/sim.70634

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。